Ardent Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.3B | $6.0B | $5.4B | $5.1B | — |
| Pretax income | $286.4M | $363.1M | $151.6M | $311.5M | — |
| Income tax expense | $56.2M | $63.4M | $22.6M | $46.1M | — |
| Net income | $135.8M | $210.3M | $53.9M | $188.9M | — |
| Balance Sheet | |||||
| Cash and equivalents | $709.6M | $556.8M | $437.6M | — | — |
| Current assets | $2.1B | $1.8B | $1.6B | — | — |
| Total assets | $5.3B | $5.0B | $4.7B | — | — |
| Current liabilities | $1.0B | $945.4M | $994.1M | — | — |
| Total liabilities | $3.6B | $3.4B | $3.6B | — | — |
| Total debt | $1.1B | $1.1B | $1.2B | — | — |
| Stockholders' equity | $1.3B | $1.1B | $670.9M | $1.0B | $978.3M |
| Cash Flow Statement | |||||
| Cash from operations | $470.5M | $315.0M | $221.7M | -$38.4M | — |
| Depreciation and amortization | $155.7M | $146.3M | $140.8M | $138.2M | — |
| Capital expenditure | $16.4M | $9.3M | $16.4M | $9.7M | — |
| Free cash flow | $454.1M | $305.8M | $205.3M | -$48.1M | — |
| Dividends paid | — | $0 | $0 | $174.8M | — |
| Share repurchases | $3.2M | — | — | — | — |
| Impairments | — | $0 | $0 | $0 | — |
Shares outstanding 143.4M · Free float 22.9%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.